FIELD: medicine, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to new applying EP4 receptors agonist for treatment and/or prophylaxis of diseases associated with loss of osseous mass. Agonists of EP4 receptors show high effectiveness in treatment of diseases associated with loss of osseous mass, among the, as osteoporosis of different genesis. Agonists of EP4 receptors involve prostaglandin skeleton base.
EFFECT: valuable medicinal properties of pharmaceutical composition.
16 cl, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 5-THIA-ω-SUBSTITUTED PHENYLPROSTAGLANDIN E, METHODS FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2220135C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT DISEASES ASSOCIATED WITH REDUCING OSSEOUS MASS AND COMPRISING EP AGONIST AS ACTIVE COMPONENT | 2002 |
|
RU2303451C2 |
PIPERIDINE/PIPERAZINE DERIVATIVES | 2008 |
|
RU2470017C2 |
USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
METHOD OF PRODUCING PYRIPYROPENE DERIVATIVES AND INTERMEDIATE PRODUCTS FOR PRODUCTION THEREOF | 2008 |
|
RU2494101C2 |
1,2,4-TRIAZINE-6-ONE DERIVATIVES, INHIBITING HIV | 2005 |
|
RU2401833C2 |
AMINOBENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | 2004 |
|
RU2332414C2 |
FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS | 2003 |
|
RU2320670C2 |
AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF REPLICATION OF RESPIRATORY SYNCYTIAL VIRUS | 2004 |
|
RU2379302C2 |
HIV-INHIBITING 5-CARBO- OR HETEROCYCLIC SUBSTITUTED PYRIMIDINES | 2005 |
|
RU2403244C2 |
Authors
Dates
2005-09-10—Published
2000-11-22—Filed